Global and China RNA Drugs Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the RNA Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Silence Therapeutics

    • Senesco

    • Benitec Biopharma

    • Calimmune Inc

    • Tekmira

    • Abbott Laboratories

    • Pfizer

    • Dicerna

    • Alnylam Pharmaceuticals

    • Gradalis

    • Sanofi-Aventis

    • Silenseed

    • Roche

    • Quark

    • Arrowhead Pharmaceuticals

    • RXi

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • siRNA

    • ASO

    • miRNA

    • Nucleic Acid Aptamers

    Application:

    • Cancer

    • Diabetes

    • Tuberculosis

    • Cardiovascular Diseases

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 RNA Drugs Industry Overview

      • 1.1.1 RNA Drugs Market Scope and Market Segments

      • 1.1.2 RNA Drugs Industry Characteristics

      • 1.1.3 Global and China RNA Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China RNA Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global RNA Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 siRNA

      • 1.2.2 ASO

      • 1.2.3 miRNA

      • 1.2.4 Nucleic Acid Aptamers

    • 1.3 Global RNA Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Cancer

      • 1.3.2 Diabetes

      • 1.3.3 Tuberculosis

      • 1.3.4 Cardiovascular Diseases

      • 1.3.5 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America RNA Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe RNA Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC RNA Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa RNA Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global RNA Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global RNA Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China RNA Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China RNA Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global RNA Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 RNA Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 RNA Drugs Industry PEST Analysis

    • 2.3 RNA Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 RNA Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on RNA Drugs Industry

    Chapter 3 Global and China RNA Drugs Market, by Manufacturer

    • 3.1 Global and China RNA Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China RNA Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China RNA Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China RNA Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China RNA Drugs Market Top 3 Players

    Chapter 4 Global and China RNA Drugs Market, by Type (2017-2028)

    • 4.1 RNA Drugs Market Trend, by Type

    • 4.2 Global RNA Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global RNA Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global RNA Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global RNA Drugs Price Trend, by Type (2017-2028)

    • 4.3 China RNA Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China RNA Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China RNA Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China RNA Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China RNA Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global RNA Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global RNA Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global RNA Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China RNA Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China RNA Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China RNA Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global RNA Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China RNA Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America RNA Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe RNA Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC RNA Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa RNA Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America RNA Drugs Market Analysis

    • 7.1 North America RNA Drugs Market, by Type

    • 7.2 North America RNA Drugs Market, by Application

    • 7.3 North America RNA Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe RNA Drugs Market Analysis

    • 8.1 Europe RNA Drugs Market, by Type

    • 8.2 Europe RNA Drugs Market, by Application

    • 8.3 Europe RNA Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC RNA Drugs Market Analysis

    • 9.1 APAC RNA Drugs Market, by Type

    • 9.2 APAC RNA Drugs Market, by Application

    • 9.3 APAC RNA Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa RNA Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa RNA Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa RNA Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa RNA Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina RNA Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China RNA Drugs Company Profiles

      • 11.1 Silence Therapeutics

        • 11.1.1 Silence Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Silence Therapeutics RNA Drugs Product Profiles, Application and Specification

        • 11.1.3 Silence Therapeutics RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Senesco

        • 11.2.1 Senesco Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Senesco RNA Drugs Product Profiles, Application and Specification

        • 11.2.3 Senesco RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Benitec Biopharma

        • 11.3.1 Benitec Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Benitec Biopharma RNA Drugs Product Profiles, Application and Specification

        • 11.3.3 Benitec Biopharma RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Calimmune Inc

        • 11.4.1 Calimmune Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Calimmune Inc RNA Drugs Product Profiles, Application and Specification

        • 11.4.3 Calimmune Inc RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Tekmira

        • 11.5.1 Tekmira Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Tekmira RNA Drugs Product Profiles, Application and Specification

        • 11.5.3 Tekmira RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Abbott Laboratories

        • 11.6.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Abbott Laboratories RNA Drugs Product Profiles, Application and Specification

        • 11.6.3 Abbott Laboratories RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Pfizer

        • 11.7.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Pfizer RNA Drugs Product Profiles, Application and Specification

        • 11.7.3 Pfizer RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Dicerna

        • 11.8.1 Dicerna Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Dicerna RNA Drugs Product Profiles, Application and Specification

        • 11.8.3 Dicerna RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Alnylam Pharmaceuticals

        • 11.9.1 Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Alnylam Pharmaceuticals RNA Drugs Product Profiles, Application and Specification

        • 11.9.3 Alnylam Pharmaceuticals RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Gradalis

        • 11.10.1 Gradalis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Gradalis RNA Drugs Product Profiles, Application and Specification

        • 11.10.3 Gradalis RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Sanofi-Aventis

        • 11.11.1 Sanofi-Aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Sanofi-Aventis RNA Drugs Product Profiles, Application and Specification

        • 11.11.3 Sanofi-Aventis RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Silenseed

        • 11.12.1 Silenseed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Silenseed RNA Drugs Product Profiles, Application and Specification

        • 11.12.3 Silenseed RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Roche

        • 11.13.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Roche RNA Drugs Product Profiles, Application and Specification

        • 11.13.3 Roche RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Quark

        • 11.14.1 Quark Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Quark RNA Drugs Product Profiles, Application and Specification

        • 11.14.3 Quark RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Arrowhead Pharmaceuticals

        • 11.15.1 Arrowhead Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Arrowhead Pharmaceuticals RNA Drugs Product Profiles, Application and Specification

        • 11.15.3 Arrowhead Pharmaceuticals RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 RXi

        • 11.16.1 RXi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 RXi RNA Drugs Product Profiles, Application and Specification

        • 11.16.3 RXi RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 RNA Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 RNA Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 RNA Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global RNA Drugs Production Value and Growth Rate (2017-2028)

    • Figure China RNA Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global RNA Drugs Market Size and Growth Rate of siRNA (2017-2028)

    • Figure Global RNA Drugs Market Size and Growth Rate of ASO (2017-2028)

    • Figure Global RNA Drugs Market Size and Growth Rate of miRNA (2017-2028)

    • Figure Global RNA Drugs Market Size and Growth Rate of Nucleic Acid Aptamers (2017-2028)

    • Figure Global RNA Drugs Market Size and Growth Rate of Cancer (2017-2028)

    • Figure Global RNA Drugs Market Size and Growth Rate of Diabetes (2017-2028)

    • Figure Global RNA Drugs Market Size and Growth Rate of Tuberculosis (2017-2028)

    • Figure Global RNA Drugs Market Size and Growth Rate of Cardiovascular Diseases (2017-2028)

    • Figure Global RNA Drugs Market Size and Growth Rate of Others (2017-2028)

    • Figure North America RNA Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe RNA Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC RNA Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa RNA Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global RNA Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China RNA Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China RNA Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China RNA Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China RNA Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China RNA Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China RNA Drugs Market Share, by Manufacturer in 2022

    • Table Global RNA Drugs Sales Volume, by Type (2017-2028)

    • Table Global RNA Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global RNA Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global RNA Drugs Sales Value, by Type (2017-2028)

    • Table Global RNA Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global RNA Drugs Price Trend, by Type (2017-2028)

    • Table China RNA Drugs Sales Volume, by Type (2017-2028)

    • Table China RNA Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China RNA Drugs Sales Volume Share, by Type (2017-2028)

    • Table China RNA Drugs Sales Value, by Type (2017-2028)

    • Table China RNA Drugs Sales Value Share, by Type (2017-2028)

    • Figure China RNA Drugs Price Trend, by Type (2017-2028)

    • Table Global RNA Drugs Sales Volume, by Application (2017-2028)

    • Table Global RNA Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global RNA Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global RNA Drugs Sales Value, by Application (2017-2028)

    • Table Global RNA Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global RNA Drugs Sales Value Share, by Application (2017-2028)

    • Table China RNA Drugs Sales Volume, by Application (2017-2028)

    • Table China RNA Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China RNA Drugs Sales Volume Share, by Application (2017-2028)

    • Table China RNA Drugs Sales Value, by Application (2017-2028)

    • Table China RNA Drugs Sales Value Share, by Application (2017-2028)

    • Figure China RNA Drugs Sales Value Share, by Application (2017-2028)

    • Figure China RNA Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America RNA Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe RNA Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC RNA Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa RNA Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America RNA Drugs Sales Volume, by Type (2017-2028)

    • Table North America RNA Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America RNA Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America RNA Drugs Sales Volume, by Application (2017-2028)

    • Table North America RNA Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America RNA Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe RNA Drugs Sales Volume, by Type (2017-2028)

    • Table Europe RNA Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe RNA Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe RNA Drugs Sales Volume, by Application (2017-2028)

    • Table Europe RNA Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe RNA Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC RNA Drugs Sales Volume, by Type (2017-2028)

    • Table APAC RNA Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC RNA Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC RNA Drugs Sales Volume, by Application (2017-2028)

    • Table APAC RNA Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC RNA Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa RNA Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa RNA Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa RNA Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa RNA Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa RNA Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa RNA Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina RNA Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina RNA Drugs Sales Value and Growth Rate (2017-2028)

    • Table Silence Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Silence Therapeutics Product Profiles, Application and Specification

    • Table Silence Therapeutics RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Senesco Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Senesco Product Profiles, Application and Specification

    • Table Senesco RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Benitec Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Benitec Biopharma Product Profiles, Application and Specification

    • Table Benitec Biopharma RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Calimmune Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Calimmune Inc Product Profiles, Application and Specification

    • Table Calimmune Inc RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Tekmira Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tekmira Product Profiles, Application and Specification

    • Table Tekmira RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories Product Profiles, Application and Specification

    • Table Abbott Laboratories RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dicerna Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dicerna Product Profiles, Application and Specification

    • Table Dicerna RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alnylam Pharmaceuticals Product Profiles, Application and Specification

    • Table Alnylam Pharmaceuticals RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gradalis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gradalis Product Profiles, Application and Specification

    • Table Gradalis RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi-Aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi-Aventis Product Profiles, Application and Specification

    • Table Sanofi-Aventis RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Silenseed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Silenseed Product Profiles, Application and Specification

    • Table Silenseed RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Quark Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Quark Product Profiles, Application and Specification

    • Table Quark RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Arrowhead Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Arrowhead Pharmaceuticals Product Profiles, Application and Specification

    • Table Arrowhead Pharmaceuticals RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table RXi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table RXi Product Profiles, Application and Specification

    • Table RXi RNA Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.